Iterum Therapeutics plc - Ordinary Share (NQ: ITRM )
1.540
+0.040
(+2.67%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about Iterum Therapeutics plc - Ordinary Share
![](https://ml.globenewswire.com/media/84454564-d67c-4843-bae2-d5851f128cc5/small/iterum-logo-jpg.jpg)
Iterum Therapeutics Reports Employment Inducement Grant
January 11, 2023
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
January 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/15/image-third_harmonic_bio_.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/11/aapharma_17.png?width=1200&height=800&fit=crop)
Iterum Therapeutics Shares Are Surging - Read Why
July 11, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23603.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 15, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/84454564-d67c-4843-bae2-d5851f128cc5/small/iterum-logo-jpg.jpg)
12 Health Care Stocks Moving In Thursday's After-Market Session
November 24, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/84454564-d67c-4843-bae2-d5851f128cc5/small/iterum-logo-jpg.jpg)
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
November 10, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/84454564-d67c-4843-bae2-d5851f128cc5/small/iterum-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/84454564-d67c-4843-bae2-d5851f128cc5/small/iterum-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/84454564-d67c-4843-bae2-d5851f128cc5/small/iterum-logo-jpg.jpg)
Iterum Therapeutics to Present Data at IDWeek 2022
October 17, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/08/18/image_6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/17/image_5.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/valuestock_image_2521.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/13/image31.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12355.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/12/image20.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/12/image_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/12/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/11/image31.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12252.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/07/11/image28.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/11/image9_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/valuestock_image_2006.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/shortsqueeze1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/08/pills.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12201.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/06/30/image34.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free